Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects

Update Il y a 5 ans
Reference: NCT01208285

Woman and Man

Extract

The purpose of this study is to investigate the pharmacokinetics and safety of a single dose of VX-770 in subjects with moderate hepatic impairment.


Inclusion criteria

  • In Development for Cystic Fibrosis

Links